Exact Mass: 466.1933
Exact Mass Matches: 466.1933
Found 500 metabolites which its exact mass value is equals to given mass value 466.1933
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
staurosporine
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D004791 - Enzyme Inhibitors Staurosporine is a potent, ATP-competitive and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively. Staurosporine also inhibits TAOK2 with an IC50 of 3 μM. Staurosporine is an apoptosis inducer[1][2][3][4][5].
Staurosporine, from Streptomyces species
Clobetasol propionate
Nimbolide
Nimbolide is a triterpene derived from the leaves and flowers of neem (Azadirachta indica). Nimbolide induces apoptosis through inactivation of NF-κB. Nimbolide inhibits CDK4/CDK6 kinase activity. Nimbolide suppresses the NF-κB, Wnt, PI3K-Akt, MAPK and JAK-STAT signaling pathways[1].
Agrochelin
A member of the class thiazolidines that is (3S)-3-hydroxy-2,2-dimethyl-3-[(4R)-3-methyl-1,3-thiazolidin-4-yl]propanoic acid which is substituted at position 2 by a (4R)-2-(2-hydroxy-6-pentylphenyl)-4,5-dihydro-1,3-thiazol-4-yl group. A cytotoxic antibiotic, it is produced by the fermentation of Agrobacterium.
Eriotriochin
6,10,15-trihydro-9(2-hydroxy-2-methylpropyl)-6,6-dimethyldibenzopyrano <2,3-c>xanthen-10-15-quinone|6,10,15-trihydro-9(2-hydroxy-2-methylpropyl)-6,6-dimethyldibenzo[a,i]pyrano [2,3-c]xanthen-10-15-quinone|Tecomaquinone III
3-O-beta-D-glucopyranosyl-8-O-beta-acetyl-1alphaH,5alphaH,6betaH,7alphaH-guai-3(4),10(14),11(13)-triene-15-methyl-6,12-olide|lapsanoside C
Nimbolide
Nimbolide is a triterpene derived from the leaves and flowers of neem (Azadirachta indica). Nimbolide induces apoptosis through inactivation of NF-κB. Nimbolide inhibits CDK4/CDK6 kinase activity. Nimbolide suppresses the NF-κB, Wnt, PI3K-Akt, MAPK and JAK-STAT signaling pathways[1].
1??-O-[2-(2-Methyl-5-isopropyl,3-en-bihydrofuryl)]-??-D-lactose
3-O-beta-D-glucopyranosyl-8-O-beta-acetyl-1alphaH,5alphaH,6betaH,7alphaH-guai-4(15),10(14),11(13)-triene-6,12-olide|lapsanoside A
2-(4-hydroxyphenyl)ethyl 4,6-O-[(1R,4E)-3-(carboxymethyl)-4-formylhex-4-en-1-ylidene]-beta-Dglucopyranoside|ilexin B
trans-2-{3-O-acetyl-4-O-[(E)-4-hydroxycinnamoyl]-beta-D-glucopyranosyloxy}cyclohexanol
1alpha-(3-furanoyloxy)-9beta-benzoyloxy-2-oxo-dihydro-beta-agarofuran
(+)-arisugacin B|(4aR,6aR,12aR,12bS)-4a,6,6a,12,12a,12b-hexahydro-4a,12alpha-dihydroxy-4,4,6a,12b-tetramethyl-9-(4-methoxyphenyl)-4H,11H-naphtho[2,1-b]pyrano[3,4-e]pyran-1,11(5H)-dione|arisugacin B
(4alpha,4alpha,6alpha,7alpha,15alpha)-7,15:21,23-diepoxy-6-hydroxy-4,8-dimethyl-1-oxo-18,24-dinor-11,12-secochola-2,16,20,22-tetraene-4,11-dicarboxylic acid gamma-lactone methyl ester|isonimbolide
taraxinic acid beta-(6-O-acetyl)-glucopyranosyl ester
Me ester, 4-O-beta-D-glucopyranoside-1, 4-Dihydroxy-3-(3-hydroxy-3-methylbutyl)-2-napthalenecarboxylic acid
(4R,5S,7R,8S)-4-O-(6-acetyl-beta-D-glucopyranosido)-9-oxoguaia-1(10),11(13)-dien-8,12-olide
3-(2-hydroxypropyl)-9-(1-hydroxy-6,8-dimethyl-3-oxodeca-1,4,6-trienyl)-(6aR)-6a-methyl-6aH-furo[2,3-h]isochromene-6,8-dione|sassafrin C
2-Naphthalenecarboxylic acid, 4-(D-glucopyranosyloxy)-1-hydroxy-3-(3-hydroxy-3-methylbutyl)-, methyl ester
[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
Clobetasol propionate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2837
Ala Asp Val Tyr
Ala Asp Tyr Val
Ala Glu Phe Thr
Ala Glu Thr Phe
Ala Phe Glu Thr
Ala Phe Thr Glu
Ala Thr Glu Phe
Ala Thr Phe Glu
Ala Val Asp Tyr
Ala Val Tyr Asp
Ala Tyr Asp Val
Ala Tyr Val Asp
Cys Phe Pro Thr
Cys Phe Thr Pro
Cys Ile Met Thr
Cys Ile Thr Met
Cys Leu Met Thr
Cys Leu Thr Met
Cys Met Ile Thr
Cys Met Leu Thr
Cys Met Thr Ile
Cys Met Thr Leu
Cys Pro Phe Thr
Cys Pro Thr Phe
Cys Thr Phe Pro
Cys Thr Ile Met
Cys Thr Leu Met
Cys Thr Met Ile
Cys Thr Met Leu
Cys Thr Pro Phe
Asp Ala Val Tyr
Asp Ala Tyr Val
Asp Phe Ser Val
Asp Phe Val Ser
Asp Gly Ile Tyr
Asp Gly Leu Tyr
Asp Gly Tyr Ile
Asp Gly Tyr Leu
Asp Ile Gly Tyr
Asp Ile Tyr Gly
Asp Leu Gly Tyr
Asp Leu Tyr Gly
Asp Ser Phe Val
Asp Ser Val Phe
Asp Val Ala Tyr
Asp Val Phe Ser
Asp Val Ser Phe
Asp Val Tyr Ala
Asp Tyr Ala Val
Asp Tyr Gly Ile
Asp Tyr Gly Leu
Asp Tyr Ile Gly
Asp Tyr Leu Gly
Asp Tyr Val Ala
Glu Ala Phe Thr
Glu Ala Thr Phe
Glu Phe Ala Thr
Glu Phe Thr Ala
Glu Gly Val Tyr
Glu Gly Tyr Val
Glu Thr Ala Phe
Glu Thr Phe Ala
Glu Val Gly Tyr
Glu Val Tyr Gly
Glu Tyr Gly Val
Glu Tyr Val Gly
Phe Ala Glu Thr
Phe Ala Thr Glu
Phe Cys Pro Thr
Phe Cys Thr Pro
Phe Asp Ser Val
Phe Asp Val Ser
Phe Glu Ala Thr
Phe Glu Thr Ala
Phe Pro Cys Thr
Phe Pro Thr Cys
Phe Ser Asp Val
Phe Ser Val Asp
Phe Thr Ala Glu
Phe Thr Cys Pro
Phe Thr Glu Ala
Phe Thr Pro Cys
Phe Val Asp Ser
Phe Val Ser Asp
Gly Asp Ile Tyr
Gly Asp Leu Tyr
Gly Asp Tyr Ile
Gly Asp Tyr Leu
Gly Glu Val Tyr
Gly Glu Tyr Val
Gly Ile Asp Tyr
Gly Ile Tyr Asp
Gly Leu Asp Tyr
Gly Leu Tyr Asp
Gly Met Pro Tyr
Gly Met Tyr Pro
Gly Asn Asn Tyr
Gly Asn Tyr Asn
Gly Pro Met Tyr
Gly Pro Tyr Met
Gly Val Glu Tyr
Gly Val Tyr Glu
Gly Tyr Asp Ile
Gly Tyr Asp Leu
Gly Tyr Glu Val
Gly Tyr Ile Asp
Gly Tyr Leu Asp
Gly Tyr Met Pro
Gly Tyr Asn Asn
Gly Tyr Pro Met
Gly Tyr Val Glu
His His Ser Ser
His Ser His Ser
His Ser Ser His
Ile Cys Met Thr
Ile Cys Thr Met
Ile Asp Gly Tyr
Ile Asp Tyr Gly
Ile Gly Asp Tyr
Ile Gly Tyr Asp
Ile Met Cys Thr
Ile Met Thr Cys
Ile Thr Cys Met
Ile Thr Met Cys
Ile Tyr Asp Gly
Ile Tyr Gly Asp
Leu Cys Met Thr
Leu Cys Thr Met
Leu Asp Gly Tyr
Leu Asp Tyr Gly
Leu Gly Asp Tyr
Leu Gly Tyr Asp
Leu Met Cys Thr
Leu Met Thr Cys
Leu Thr Cys Met
Leu Thr Met Cys
Leu Tyr Asp Gly
Leu Tyr Gly Asp
Met Cys Ile Thr
Met Cys Leu Thr
Met Cys Thr Ile
Met Cys Thr Leu
Met Gly Pro Tyr
Met Gly Tyr Pro
Met Ile Cys Thr
Met Ile Thr Cys
Met Leu Cys Thr
Met Leu Thr Cys
Met Met Ser Val
Met Met Val Ser
Met Pro Gly Tyr
Met Pro Tyr Gly
Met Ser Met Val
Met Ser Val Met
Met Thr Cys Ile
Met Thr Cys Leu
Met Thr Ile Cys
Met Thr Leu Cys
Met Val Met Ser
Met Val Ser Met
Met Tyr Gly Pro
Met Tyr Pro Gly
Asn Gly Asn Tyr
Asn Gly Tyr Asn
Asn Asn Gly Tyr
Asn Asn Tyr Gly
Asn Tyr Gly Asn
Asn Tyr Asn Gly
Pro Cys Phe Thr
Pro Cys Thr Phe
Pro Phe Cys Thr
Pro Phe Thr Cys
Pro Gly Met Tyr
Pro Gly Tyr Met
Pro Met Gly Tyr
Pro Met Tyr Gly
Pro Ser Thr Tyr
Pro Ser Tyr Thr
Pro Thr Cys Phe
Pro Thr Phe Cys
Pro Thr Ser Tyr
Pro Thr Tyr Ser
Pro Tyr Gly Met
Pro Tyr Met Gly
Pro Tyr Ser Thr
Pro Tyr Thr Ser
Ser Asp Phe Val
Ser Asp Val Phe
Ser Phe Asp Val
Ser Phe Val Asp
Ser His His Ser
Ser His Ser His
Ser Met Met Val
Ser Met Val Met
Ser Pro Thr Tyr
Ser Pro Tyr Thr
Ser Ser His His
Ser Thr Pro Tyr
Ser Thr Tyr Pro
Ser Val Asp Phe
Ser Val Phe Asp
Ser Val Met Met
Ser Tyr Pro Thr
Ser Tyr Thr Pro
Thr Ala Glu Phe
Thr Ala Phe Glu
Thr Cys Phe Pro
Thr Cys Ile Met
Thr Cys Leu Met
Thr Cys Met Ile
Thr Cys Met Leu
Thr Cys Pro Phe
Thr Glu Ala Phe
Thr Glu Phe Ala
Thr Phe Ala Glu
Thr Phe Cys Pro
Thr Phe Glu Ala
Thr Phe Pro Cys
Thr Ile Cys Met
Thr Ile Met Cys
Thr Leu Cys Met
Thr Leu Met Cys
Thr Met Cys Ile
Thr Met Cys Leu
Thr Met Ile Cys
Thr Met Leu Cys
Thr Pro Cys Phe
Thr Pro Phe Cys
Thr Pro Ser Tyr
Thr Pro Tyr Ser
Thr Ser Pro Tyr
Thr Ser Tyr Pro
Thr Tyr Pro Ser
Thr Tyr Ser Pro
Val Ala Asp Tyr
Val Ala Tyr Asp
Val Asp Ala Tyr
Val Asp Phe Ser
Val Asp Ser Phe
Val Asp Tyr Ala
Val Glu Gly Tyr
Val Glu Tyr Gly
Val Phe Asp Ser
Val Phe Ser Asp
Val Gly Glu Tyr
Val Gly Tyr Glu
Val Met Met Ser
Val Met Ser Met
Val Ser Asp Phe
Val Ser Phe Asp
Val Ser Met Met
Val Tyr Ala Asp
Val Tyr Asp Ala
Val Tyr Glu Gly
Val Tyr Gly Glu
Tyr Ala Asp Val
Tyr Ala Val Asp
Tyr Asp Ala Val
Tyr Asp Gly Ile
Tyr Asp Gly Leu
Tyr Asp Ile Gly
Tyr Asp Leu Gly
Tyr Asp Val Ala
Tyr Glu Gly Val
Tyr Glu Val Gly
Tyr Gly Asp Ile
Tyr Gly Asp Leu
Tyr Gly Glu Val
Tyr Gly Ile Asp
Tyr Gly Leu Asp
Tyr Gly Met Pro
Tyr Gly Asn Asn
Tyr Gly Pro Met
Tyr Gly Val Glu
Tyr Ile Asp Gly
Tyr Ile Gly Asp
Tyr Leu Asp Gly
Tyr Leu Gly Asp
Tyr Met Gly Pro
Tyr Met Pro Gly
Tyr Asn Gly Asn
Tyr Asn Asn Gly
Tyr Pro Gly Met
Tyr Pro Met Gly
Tyr Pro Ser Thr
Tyr Pro Thr Ser
Tyr Ser Pro Thr
Tyr Ser Thr Pro
Tyr Thr Pro Ser
Tyr Thr Ser Pro
Tyr Val Ala Asp
Tyr Val Asp Ala
Tyr Val Glu Gly
Tyr Val Gly Glu
[3-[6-methoxy-1,3-dioxo-1H-benz[de]-2(3H)-isoquinolyl]-2,2-dimethylpropyl]trimethylammonium methyl sulphate
4-methoxyphenyl 2,6-di-o-benzyl-beta-d-galactopyranoside
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
H-D-Tyr-Pro-Arg-chloromethylketone trifluoroacetate salt
Thymol blue
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D010635 - Phenolphthaleins
H-D-Phe-Pro-Arg-chloromethylketone trifluoroacetate salt
2-Methyl-2-propanyl 4-{2-fluoro-5-[(4-oxo-3,4-dihydro-1-phthalazi nyl)methyl]benzoyl}-1-piperazinecarboxylate
Diphenylmethyl (2R)-3-methyl-2-[3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]-3-butenoate
Rogaratinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
5,7,4-Trihydroxy-3,6-dimethoxy-3,5-diprenylflavone
Ethyl 4-((methyl(3-(pyridin-4-yl)benzyl)carbamoyl)oxy)-[1,1-biphenyl]-4-carboxylate
Arisugacin B
An organic heterotetracyclic compound that is 4a,12a-dihydroxy-4,4,6a,12b-tetramethyl-4a,6,6a,12,12a,12b-hexahydro-4H,11H-benzo[f]pyrano[4,3-b]chromene-1,11(5H)-dione substituted by a 4-methoxyphenyl group at position 9 (the 4aR,6aR,12aS,12bS steroisomer). Isolated from the culture broth of Penicillium, it acts as a selective inhibitor of acetylcholinesterase.
(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3,2,1-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one
(5R)-3-phenyl-1-(phenylmethyl)spiro[1,3-diazinane-5,5-2,4,4a,6-tetrahydro-1H-pyrazino[1,2-a]quinoline]-2,4,6-trione
[4-[Bis(4-methoxyphenyl)methyl]-1-piperazinyl]-(5-methyl-4-nitro-3-isoxazolyl)methanone
Ala-Val-Asp-Tyr
A tetrapeptide composed of L-alanine, L-valine, L-aspartic acid, and L-tyrosine joined in sequence by peptide linkages.
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[4-(trifluoromethyl)phenyl]carbamoylamino]ethyl]oxan-3-yl]pyridine-3-carboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[4-(trifluoromethyl)phenyl]carbamoylamino]ethyl]oxan-3-yl]pyridine-3-carboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(1R,3S,4aR,9aS)-3-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-methoxyacetamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-2-fluoro-N-methylbenzamide
5-(2-Fluorophenyl)-4-(2-methyl-2,3-dihydro-1-benzofuran-5-carbonyl)-1-(2-morpholin-4-ylethyl)pyrrolidine-2,3-dione
[(8S,9R,10S,11S,13S,14S,16S)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[(8S,9S,10S,11R,13S,14S,16S,17S)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
KT203
KT203 is a potent and selective inhibitor of α/β-hydrolase domain containing 6 (ABHD6), with an IC50 of 0.31 nM in Neuro2A cells[1].
(6ar)-3-[(4s)-4-hydroxy-2-methyl-6-oxocyclohex-1-en-1-yl]-6a-methyl-9-octanoylfuro[2,3-h]isochromene-6,8-dione
(3ar,4r,6ar,8s,9ar,9br)-3,6,9-trimethylidene-2-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-4-yl acetate
3,6,9-trimethylidene-2-oxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-4-yl acetate
(12r,15s,23r)-16-acetyl-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetraazahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²²]tetracosa-1(24),2,4,6,8,17,19,21-octaene-10,13-dione
(2r,3r,3ar,4s,7s,7ar)-4-{[(2z)-3-[(r)-methanesulfinyl]prop-2-enoyl]oxy}-7,7a-dimethyl-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl 3-methylbutanoate
6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl 10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(2r,3r,4r,5r,6r)-4-(acetyloxy)-5-hydroxy-6-{[(1s,2s)-2-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
3-hydroxy-3-{2-[2-(2-hydroxy-6-pentylphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-3-methyl-1,3-thiazolidin-4-yl}-2,2-dimethylpropanoic acid
(26s)-26-(2-hydroxy-2-methylpropyl)-5,5-dimethyl-6,15-dioxahexacyclo[12.12.0.0²,⁷.0⁸,¹³.0¹⁶,²⁵.0¹⁸,²³]hexacosa-1(14),2(7),3,8,10,12,16(25),18,20,22-decaene-17,24-dione
5,7-dihydroxy-2-[4-hydroxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]-3,6-dimethoxychromen-4-one
1alpha-o-[2'-(2'-methane,5'-isopropyl,3'-en-bihydrofuryl)]-beta-d-lactose
{"Ingredient_id": "HBIN002316","Ingredient_name": "1alpha-o-[2'-(2'-methane,5'-isopropyl,3'-en-bihydrofuryl)]-beta-d-lactose","Alias": "NA","Ingredient_formula": "C20H34O12","Ingredient_Smile": "CC(C)C1C=CC(O1)(C)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31519","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1α-o-[2'-(2'-methyl-5'-isopropyl,3'-en-bihydro-furyl)]-β-d-lactose
{"Ingredient_id": "HBIN002317","Ingredient_name": "1\u03b1-o-[2'-(2'-methyl-5'-isopropyl,3'-en-bihydro-furyl)]-\u03b2-d-lactose","Alias": "NA","Ingredient_formula": "C20H34O12","Ingredient_Smile": "CC(C)C1C=CC(O1)(C)OC2C(C(C(C(O2)CO)OC3C(C(C(C(O3)CO)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14529","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}